{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:59:47Z","timestamp":1792011587978,"version":"4.4.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1097\/iae.0000000000000248","type":"journal-article","created":{"date-parts":[[2014,7,30]],"date-time":"2014-07-30T10:47:07Z","timestamp":1406717227000},"page":"2275-2281","source":"Crossref","is-referenced-by-count":41,"title":["RANIBIZUMAB IN THE MANAGEMENT OF ADVANCED COATS DISEASE STAGES 3B AND 4"],"prefix":"10.1097","volume":"34","author":[{"given":"Marie-Claire","family":"Gaillard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assimina","family":"Mataftsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubin","family":"Balmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis L.","family":"Munier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210130","first-page":"440","article-title":"Forms of retinal diseases with massive exudation.","volume":"17","author":"Coats","year":"1908","journal-title":"Roy Lond Ophthalmol Hosp Rep"},{"key":"R2-15-20210130","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1038\/eye.2010.126","article-title":"A population-based study of Coats disease in the United Kindom I: epidemiology and clinical features at diagnosis.","volume":"22","author":"Morris","year":"2010","journal-title":"Eye (Lond)"},{"key":"R3-15-20210130","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0002-9394(01)00896-0","article-title":". Classification and management of Coats disease: the 2000 Proctor Lecture.","volume":"131","author":"Shields","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R4-15-20210130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1001\/archopht.1974.01010010115006","article-title":"Coats disease.","volume":"92","author":"Egerer","year":"1974","journal-title":"Arch Ophthalmol"},{"key":"R5-15-20210130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF01858237","article-title":"Ueber Retintis exudativa (retinitis hemorrhagiga exerna).","volume":"81","author":"Coats","year":"1912","journal-title":"Greafs Arch Ophthalmol"},{"key":"R6-15-20210130","first-page":"855","article-title":"Coats disease. Natural history and results of treatment.","volume":"60","author":"Gomez Morales","year":"1965","journal-title":"Am J Ophthalmol"},{"key":"R7-15-20210130","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1097\/IAE.0b013e318163cd7c","article-title":"Advanced Coats disease. Management with repetitive aggressive laser ablation therapy.","volume":"28","author":"Schefler","year":"2008","journal-title":"Retina"},{"key":"R8-15-20210130","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1038\/eye.2010.127","article-title":"A population-based study of Coats disease in the United Kindom II: investigation, treatment, and outcomes.","volume":"22","author":"Mulvihill","year":"2010","journal-title":"Eye (Lond)"},{"key":"R9-15-20210130","first-page":"89","article-title":". Natural history and management of advanced Coats disease.","volume":"19","author":"Silodor","year":"1988","journal-title":"Ophthalmic Surg"},{"key":"R10-15-20210130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaapos.2005.12.001","article-title":". The effects of external subretinal fluid drainage on secondary glaucoma in Coats disease.","volume":"10","author":"Han","year":"2006","journal-title":"J AAPOS"},{"key":"R11-15-20210130","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF01268124","article-title":". Vitrectomy techniques in late-stage Coats-like exudative retinal detachment.","volume":"90","author":"Yoshizumi","year":"1995","journal-title":"Doc Ophthalmol"},{"key":"R12-15-20210130","first-page":"32","article-title":"Vitreoretinal surgery in advanced Coats disease.","volume":"4","author":"Schmidt-Erfurth","year":"1995","journal-title":"Ger J Ophthalmol"},{"key":"R13-15-20210130","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/IAE.0b013e31816b3158","article-title":". Management of retinal detachment in Coats disease. Study of 15 cases.","volume":"28","author":"Mrejen","year":"2008","journal-title":"Retina"},{"key":"R14-15-20210130","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00417-007-0559-8","article-title":"Elevated vascular endothelial growth factor levels in Coats disease: rapid response to pegaptanib sodium.","volume":"245","author":"Sun","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R15-15-20210130","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00417-010-1366-1","article-title":". Elevated vascular endothelial growth factor level in Coats disease and possible therapeutic role of bevacizumab.","volume":"248","author":"He","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R16-15-20210130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000336906","article-title":"Diagnosis and treatment of Coats disease: a review of the literature.","volume":"227","author":"Ghorbanian","year":"2012","journal-title":"Ophthalmologica"},{"key":"R17-15-20210130","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/eye.2009.336","article-title":"Coats disease associated with muscular dystrophy treated with ranibizumab.","volume":"24","author":"Diago","year":"2010","journal-title":"Eye (Lond)"},{"key":"R18-15-20210130","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1055\/s-0031-1299216","article-title":"Coats disease in a 14-year-old boy treated with intravitreal ranibizumab and retinal laser photocoagulation.","volume":"229","author":"Theoulakis","year":"2012","journal-title":"Klin Monbl Augenheilkd"},{"key":"R19-15-20210130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/0301-4738.58480","article-title":"Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Coats disease in children.","volume":"58","author":"Kaul","year":"2010","journal-title":"Indian J Ophthalmol"},{"key":"R20-15-20210130","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/IAE.0b013e3181c2e0b7","article-title":"The effect of intravitreal bevacizumab in the treatment of Coats disease in children.","volume":"30","author":"Lin","year":"2010","journal-title":"Retina"},{"key":"R21-15-20210130","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00417-010-1563-y","article-title":"Resolution of total retinal detachment in Coats disease with intravitreal injection of bevacizumab.","volume":"249","author":"Zhao","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R22-15-20210130","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/bjophthalmol-2011-300141","article-title":"Bevacizumab for Coats disease with exudative retinal detachment and risk of vitreoretinal traction.","volume":"96","author":"Ramasubramanian","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"R23-15-20210130","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.ophtha.2007.09.012","article-title":". Pharmacokinetics of intravitreal ranibizumab (Lucentis).","volume":"114","author":"Bakri","year":"2007","journal-title":"Ophthalmology"},{"key":"R24-15-20210130","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1651-2227.2011.02330.x","article-title":"On the use of antiangiogenetic medications for retinopathy of prematurity.","volume":"100","author":"Hard","year":"2011","journal-title":"Acta Paediatr"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000000248","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:04:13Z","timestamp":1620954253000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201411000-00015"}},"subtitle":["Long-term Outcomes"],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000000248","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}